Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Gustavo Heresi, MD

216.444.6503

Gustavo Heresi, MD

Appointed: 2008

Gustavo Heresi, MD
Department: Pulmonary Medicine
Location: Cleveland Clinic Main Campus
Mail Code A90
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6503
DeskDesk:216.636.5327
WorkFax:216.445.6024
Gustavo Heresi, MD
Department: Critical Care Medicine
Location: Cleveland Clinic Main Campus
Mail Code A90
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.636.5327
WorkFax:216.445.6024
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Gustavo A. Heresi, M.D. is the Medical Director of the Pulmonary Thromboendarterectomy Program in the Department of Pulmonary and Critical Care Medicine in the Respiratory Institute at Cleveland Clinic.  He is board certified in internal medicine, pulmonary disease, and critical care medicine.  Dr. Heresi's clinical interests are in pulmonary hypertension, acute pulmonary embolism, chronic thromboembolic pulmonary hypertension (CTEPH), and critical care. He is Assistant Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.

 

Dr. Heresi has focused his research efforts on his specialty interests, including risk prediction and non-invasive biomarkers of pulmonary arterial hypertension, diagnosis and management of pulmonary arterial hypertension and acute pulmonary embolism, treatment of pulmonary hypertension and right ventricular failure in the ICU, and diagnosis and treatment of CTEPH. 

Dr. Heresi has been the recipient of many awards including The Medical   Student Inpatient Teaching Award, University of Miami School of Medicine 2004;  Distinguished Medical Resident Award, Department of Medicine, University of Miami 2005;  Gilead Sciences Research Scholars Program Award in Pulmonary Arterial Hypertension 2009; Who's Who in America 2009; Best Doctors in America 2012; Young Investigator Award, American College of Chest Physicians 2012; and  Teacher of the Year Award, Cleveland Clinic Pulmonary and Critical Care Fellowship 2013-2014.

Dr. Heresi is a journal reviewer for several peer-reviewed publications including: American Journal of Respiratory and Critical Care Medicine, Chest, European Respiratory Journal, and Respiratory Care. He is a member of the American Thoracic Society (ATS), American College of Chest Physicians (ACCP), Society of Critical Care Medicine (SCCM), Pulmonary Hypertension Association (PHA), and the International CTEPH Association (ICA).

After receiving his medical degree from the University of San Agustin Faculty of Medicine in Arequipa, Peru, Dr. Heresi completed his internship and residency in internal medicine at the University of Miami-Jackson Memorial Medical Center in Miami, Fl. He completed his fellowship in pulmonary and critical care medicine at The Cleveland Clinic.

Professional Highlights

2010 - present:  Member, Education Committee, Respiratory Institute, Cleveland Clinic

2010 and 2012: Co-Director, Cleveland Clinic Pulmonary Hypertension Symposium

2011 and 2013: Co-Director, Cleveland Clinic Pulmonary Hypertension Summit

2012 Co-Chair. American Thoracic Society International Conference Scientific Symposium “Inflammation and Altered Metabolism in Pulmonary Hypertension”

2013 - present:  Member, Clinical Competencies Committee, Respiratory Institute, Cleveland Clinic

Education & Fellowships

Fellowship - Cleveland Clinic
Pulmonary / Critical Care
Cleveland, OH USA
2008
Residency - Jackson Memorial Hospital
Internal Medicine
Miami, FL USA
2005
Medical School - Universidad Nacional de San Agustin Facultad de Medicina
Arequipa Peru
2000

Certifications

  • Internal Medicine
  • Internal Medicine- Pulmonary Disease
  • Internal Medicine- Critical Care Medicine

Specialty Interests

Pulmonary hypertension, chronic thromboembolic pulmonary hypertension (CTEPH), acute pulmonary embolism, acute respiratory distress syndrome (ARDS), sepsis Acute respiratory distress syndrome (ARDS), pneumonia, pulmonary fibrosis, pulmonary hypertension, scleroderma, sepsis, Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Acute respiratory distress syndrome (ARDS), pneumonia, pulmonary fibrosis, pulmonary hypertension, scleroderma, sepsis

Awards & Honors

Gilead Sciences Research Scholars Program Award in Pulmonary Arterial Hypertension 2009

Listed in Who's Who in America 2009

Listed in Best Doctors in America 2012

Young Investigator Award, American College of Chest Physicians 2012

Teacher of the Year Award, Cleveland Clinic Pulmonary/Critical Care Fellowship Program 2013-2014

Additional Training

Master of Science in Clinical Research Program at Case Western Reserve University (in progress)

Memberships

American Thoracic Society

American College of Chest Physicians

Society of Critical Care Medicine

Pulmonary Hypertension Association

International CTEPH Association

Treatment & Services

  • Bronchoscopy
  • Cardiopulmonary Resuscitation (cpr)
  • Clinical Trials
  • Endotracheal Intubation
  • Mechanical Ventilation
  • Thrombolytic Therapy

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 3/14/2014, Dr. Heresi has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
  • Spanish